NCT06190574View on ClinicalTrials.gov

Diagnostic Efficacy and Prognostic Value of 18F-FDG PET/CT (MR) in Pediatric Solid Blastoma

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

July 30, 2021

Primary Completion Date

September 30, 2023

Study Completion Date

November 30, 2023

Conditions
18F-FDGNeuroblastomaHepatoblastomaWilms Tumor
Interventions
OTHER

Telephone follow-up

Telephone follow-up

Trial Locations (1)

430022

China, Hubei Province, Wuhan

All Listed Sponsors
lead

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

OTHER

NCT06190574 - Diagnostic Efficacy and Prognostic Value of 18F-FDG PET/CT (MR) in Pediatric Solid Blastoma | Biotech Hunter | Biotech Hunter